Absolute Risk Difference News Today

1. In this randomized controlled trial, expectant management of patent ductus arteriosus (PDA) in extremely premature infants required no active intervention unless complications arose. 2. Expectant management was shown to be noninferior to early ibuprofen in terms of preventing adverse neonatal outcomes. Evidence Rating Level: 1 (Excellent) Study Rundown: PDA is a common complication of

(0) SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / May 13, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced first quarter 2021 financial results and provided an update on the cytisinicline clinical development program. Recent Events & Highlights Provided update on the Phase 3 ORCA-2 clinical trial evaluating the efficacy ...